# A Phase I, Single-Center, Open-Label, Dose-Escalation Clinical Trial to Assess the Safety and Tolerability of an Intranasal Memory T Lymphocytes Solution in Adult Females: vRELEASE I. (vRELEASE I)

> **NCT06699758** · PHASE1 · COMPLETED · sponsor: **Cristina Calvo Rey** · enrollment: 9 (actual)

## Conditions studied

- To Assess the Safety and Tolerability of Intranasal Administration of a Male Donor Memory T Lymphocyte Solution

## Interventions

- **OTHER:** CD45RA- memory T lymphocytes cells sourced from healthy peripheral blood mononuclear cells male donors.

## Key facts

- **NCT ID:** NCT06699758
- **Lead sponsor:** Cristina Calvo Rey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-05
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699758, "A Phase I, Single-Center, Open-Label, Dose-Escalation Clinical Trial to Assess the Safety and Tolerability of an Intranasal Memory T Lymphocytes Solution in Adult Females: vRELEASE I. (vRELEASE I)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06699758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*